Victory Capital Management Inc. Raises Position in Haemonetics Co. (NYSE:HAE)

Victory Capital Management Inc. grew its position in Haemonetics Co. (NYSE:HAE – Get Rating) by 808.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 377,252 shares of the medical instruments supplier’s stock after buying an additional 335,736 shares during the period. Victory Capital Management Inc.’s holdings in […]

Related Keywords

Raymond James ,Michellel Basil ,Markw Kroll ,Morgan Stanley ,Yousif Capital Management ,Securities Exchange Commission ,Blood Center ,Emerald Advisers ,Haemonetics Corporation ,Mirae Asset Global Investments Co ,Emerald Mutual Fund Advisers ,Barrington Research ,Haemonetics Co ,Single Point Partners ,Victory Capital Management Inc ,Citigroup ,Victory Capital Management ,Get Rating ,Capital Management ,Mutual Fund Advisers Trust ,Point Partners ,Mirae Asset Global Investments ,Director Mark ,Exchange Commission ,Visit Holdingschannel ,Haemonetics Daily ,Haemonetics ,Nyse Hae ,Hae ,Medical ,40502410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,